| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.299 | 1.020 | 603 | 614 | 415 | 429 | 233 | 276 | 139.561 | 258.190 |
| Total Income - EUR | 5.299 | 1.020 | 603 | 614 | 416 | 429 | 234 | 276 | 450.593 | 268.258 |
| Total Expenses - EUR | 10.131 | 3.520 | 5.844 | 1.001 | 1.883 | 1.374 | 2.608 | 1.403 | 121.233 | 207.582 |
| Gross Profit/Loss - EUR | -4.832 | -2.500 | -5.242 | -387 | -1.466 | -945 | -2.374 | -1.127 | 329.360 | 60.676 |
| Net Profit/Loss - EUR | -4.991 | -2.520 | -5.248 | -393 | -1.471 | -949 | -2.377 | -1.129 | 324.927 | 52.424 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vitalogy Farma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.648 | 641 | 690 | 1.565 | 2.329 | 2.540 | 2.592 | 3.038 | 389.637 | 400.870 |
| Inventories | 552 | 428 | 383 | 1.272 | 2.146 | 2.219 | 2.260 | 2.549 | 85.394 | 76.010 |
| Receivables | 2.025 | 132 | 296 | 285 | 171 | 175 | 242 | 361 | 36.934 | 285.836 |
| Cash | 72 | 80 | 11 | 8 | 12 | 146 | 90 | 128 | 267.309 | 39.024 |
| Shareholders Funds | -28.633 | -30.862 | -35.587 | -35.327 | -36.114 | -36.381 | -37.951 | -39.198 | 285.847 | 336.674 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 31.297 | 31.502 | 36.277 | 36.893 | 38.443 | 38.921 | 40.543 | 42.236 | 103.790 | 64.196 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Vitalogy Farma S.r.l.